DrugPatentWatch Database Preview
Sagent Pharms Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has forty-five approved drugs.
Summary for Sagent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 40 |
| Ingredients: | 39 |
| NDAs: | 45 |
Drugs and US Patents for Sagent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-001 | Dec 29, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 091458-002 | Jul 28, 2010 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 204696-002 | Mar 2, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | OCTREOTIDE ACETATE (PRESERVATIVE FREE) | octreotide acetate | INJECTABLE;INJECTION | 090834-003 | Nov 12, 2013 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 201379-001 | Feb 28, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
